Results 91 to 100 of about 46,297 (193)

Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 7, Page 3465-3472, December 1, 2025.
ABSTRACT We aimed to compare the long‐term efficacy and safety of drug‐coated balloon (DCB) and drug‐eluting stent (DES) following atherectomy for coronary arteries with severely calcified lesions. Of the 258 consecutive patients and 422 de novo lesions treated with DCB at Kanazawa Medical University Hospital, we retrospectively enrolled highly ...
Taka‐aki Takamura   +11 more
wiley   +1 more source

Real‐World Outcome of Coronary Orbital Atherectomy in Diabetic Versus Non‐Diabetic Patients: A Single‐Center Experience

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 7, Page 3481-3488, December 1, 2025.
ABSTRACT Background and Aims Clinical trial research on the safety and efficacy of coronary orbital atherectomy (OA) in diabetics compared to non‐diabetics is limited. This single‐center study aimed to perform a diabetic comparative analysis using real‐world data.
Benjamin Klein   +9 more
wiley   +1 more source

Comparative Analysis of Intravascular Lithotripsy With and Without Atherectomy in Severely Calcified Coronary Lesions Using OCT and OFDI

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 7, Page 3541-3550, December 1, 2025.
ABSTRACT Background Intravascular lithotripsy (IVL) fractures calcified plaques and facilitates lesion expansion; however, unlike atherectomy devices, it does not reduce calcium volume. The therapeutic efficacy and safety of combining IVL with atherectomy remain unclear. Therefore, this study aimed to evaluate, through optical coherence tomography (OCT)
Marohito Nakata   +3 more
wiley   +1 more source

Roles of microRNAs in atherosclerosis and restenosis [PDF]

open access: diamond, 2012
Li Jing Chen   +4 more
openalex   +1 more source

Use of Paclitaxel-Coated Balloon Catheter Dilation to Reduce In-Stent Restenosis in Transjugular Intrahepatic Portosystemic Shunt (TIPS) [PDF]

open access: bronze, 2016
Stephan Rodrigo Marticorena Garcia   +5 more
openalex   +1 more source

Underestimation of Stent Efficacy: Untreated Artery Events Distort Coronary Intervention Outcomes

open access: yesClinical Cardiology, Volume 48, Issue 12, December 2025.
This prospective study evaluated 562 patients with stable coronary disease undergoing PCI. It was observed that 55.8% of events occurred in the treated vessel and 44.2% in untreated vessels. There was no significant difference between bare‐metal and drug‐eluting stents.
Mauricio Rigodanzo Mocha   +7 more
wiley   +1 more source

Clinical Trials With Pragmatic Elements: A Review of Use Cases and Real‐World Data Utilization

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1350-1365, December 2025.
Clinical trials with pragmatic elements can capture diverse patient populations, enable efficient follow‐up, and reflect routine clinical practices; yet there is limited understanding of their design features, characteristics, and use of real‐world data (RWD). Based on a targeted search of PubMed/EMBASE (Jan‐2016 to Jul‐2024), a review was conducted to
Le Su   +6 more
wiley   +1 more source

Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study

open access: yesCVIR Endovascular
Background The clinical implications of restenosis after drug-coated balloon (DCB) treatment remain unclear. We compared the clinical outcomes between DCB angioplasty for restenosis and de novo femoropopliteal artery lesions.
Takuya Haraguchi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy